preferred_name: Monitor for neuromuscular manifestations of hypophosphatemia (e.g., weakness, lassitude, malaise, tremors, paresthesias, ataxia, muscle pain, increased creatinine phosphokinase, abnormal EMG, and rhabdomyolysis)